Form D To Observe: Patara Pharma $6.00 million Financing. William M Gerhart Published Oct 13 Form D

Biotechnology Patara Pharma, Llc - William M Gerhart

Patara Pharma Financing

Patara Pharma, Llc, Limited Liability Company just released form D because of $6.00 million equity financing. This is a new filing. Patara Pharma was able to fundraise $6.00 million. That is 100.00% of the offering. The total private offering amount was $6.00 million. The fundraising form was filed on 2016-10-13. The reason for the financing was: unspecified.

Patara Pharma is based in California. The firm’s business is Biotechnology. The form was signed by William M Gerhart Managing Member of Managing Member of Issuer. The company was incorporated in 2013. The filler’s address is: 11455 El Camino Real, Suite 460, San Diego, Ca, California, 92130. Bernoulli Pharma Holdings, Llc is the related person in the form and it has address: 11455 El Camino Real, Suite 460, San Diego, Ca, California, 92130. Link to Patara Pharma Filing: 000114036116082691.

Analysis of Patara Pharma Offering

On average, companies in the Biotechnology sector, sell 73.77% of the total offering amount. Patara Pharma sold 100.00% of the offering. Could this mean that the trust in Patara Pharma is high? The average investment size for companies in the Biotechnology industry is $3.08 million. The total amount raised is 94.81% bigger than the average for companies in the Biotechnology sector. The minimum investment for this financing was set at $0. If you know more about the reasons for the financing, please comment below.

What is Form D? What It Is Used For

Form D disclosures could be used to track and understand better your competitors. The information in Form D is usually highly confidential for ventures and startups and they don’t like revealing it. This is because it reveals amount raised or planned to be raised as well as reasons for the financing. This could help competitors. Entrepreneurs usually want to keep their financing a ‘secret’ so they can stay in stealth mode for longer.

Why Fundraising Reporting Is Good For Patara Pharma Also

The Form D signed by William M Gerhart might help Patara Pharma, Llc’s sector. First, it helps potential customers feel more safe to deal with a firm that is well financed. The odds are higher that it will stay in the business. Second, this could attract other investors such as venture-capital firms, funds and angels. Third, positive PR effects could even bring leasing firms and venture lenders.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment